2 sub‑$10 AI stocks to outperform Palantir in 2026, according to ChatGPT‑5

Core Insights - Palantir Technologies (NASDAQ: PLTR) has established itself as a leader in AI-driven data analytics, securing significant government contracts and expanding its intelligence business, resulting in a 105% stock price increase year-to-date, trading at $154 [1][2] Company Summaries BigBear.ai (NYSE: BBAI) - BigBear.ai is undergoing a strategic pivot, highlighted by its acquisition of Ask Sage, a generative AI platform for secure sectors like defense, which is expected to generate approximately $25 million in annual recurring revenue in 2025 [3][5] - The acquisition positions BigBear to transition from a decision-intelligence contractor to a full-stack generative AI provider, enhancing its offerings for government clients [4] - With over $450 million in cash, BigBear has the financial flexibility to support growth initiatives and strategic investments, potentially allowing it to carve out a unique position in the defense AI sector [5][6] Lantern Pharma (NASDAQ: LTRN) - Lantern Pharma utilizes its RADR AI platform to innovate oncology drug development, leveraging over 200 billion data points and 200 machine-learning algorithms [7] - The company has shown promising clinical results, with a 48% clinical benefit rate in its LP-184 Phase 1a trial among heavily pretreated patients [8][9] - Lantern is managing its cash effectively, with $19.7 million available, and plans to commercialize parts of its RADR platform, which could generate revenue through licensing [9]